GlassScriptPhysician profile
Rong Shi
NPI 1669630521
$591.13
in general payments reported to CMS, 2019-2025
14 companies · $41.45 in 2025
The $41.45 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $52.14 · 2023: $112 · 2024: $49.31 · 2025: $41.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $126.49 | 2023-2025 | Mounjaro, Zepbound |
| Actelion Pharmaceuticals US, INC. | $119.85 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.57 | 2019 | |
| Scilex Pharmaceuticals INC. | $42.43 | 2019 | |
| Allergan, INC. | $35.04 | 2020 | |
| Astellas Pharma US INC | $26.62 | 2019 | |
| Abbott Laboratories | $23.19 | 2019 | |
| Dexcom, INC. | $22.56 | 2023 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $21.34 | 2023 | |
| Mylan Specialty L.P. | $20.07 | 2019 | |
| Neotract INC. | $19.19 | 2019 | |
| Novo Nordisk INC | $17.10 | 2020 | |
| Amgen INC. | $17.01 | 2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $15.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rong Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.